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alternative to PST as a method of accelerated throm- 
bolysis. However, side effects using this technique, 
such as haemorrhage and distal embolisation, may be 
increased. 3 This must be balanced against complica- 
tions due to prolonged catheter insertion using con- 
ventional techniques. Further evaluation of both 
methods of accelerated thrombolysis is therefore 
needed before they become the treatment of choice. 
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LMWH In Vein Grafts 
Sir, 
Wilson et aI. 1 suggest that low molecular weight 
heparin (LMWH) administered to rabbits inhibits the 
development of intimal hyperplasia in arteries under- 
going vascular grafting. This finding is of considerable 
potential clinical relevance. A few comments may be 
of interest. 
Unfractionated heparin (UH), at concentrations 
achieved uring treatment, significantly enhances and 
induces platelet aggregation, in vitro, in samples 
obtained from patients with ischaemic heart disease 
(IHD) 2-4 or peripheral vascular disease (PVD). 5 In 
contrast, the addition of LMWH, or a LMW Hep- 
arinoid, did not reproduce this effect. 4'5 Similarl)~ the 
administration of UH, but not of a LMW Heparinoid, 
to healthy volunteers was associated with enhanced 
platelet aggregation. 6 Thus, platelets from patients 
that may require vascular surgery may be susceptible 
to stimulation by UH but not LMWH. Furthermore, 
platelet activation is associated with thrombus forma- 
tion as well as with the release of intraplatelet growth 
factors (e.g. PDGF, serotonin). Thus, in contrast to UH, 
LMWH administration pre-, intra- and postoper- 
atively is less likely to increase the release of these 
growth factors. In this context, it is relevant that 
although aspirin (a potent inhibitor of platelet aggre- 
gation) can prolong the life span of vascular grafts, it 
is ineffective if administered more than 2-3 days after 
surgery. 7 This observation suggests that decreasing 
platelet activity in the peri-operative p riod may be of 
considerable importance. 
In conclusion, LMWH use in patients undergoing 
vascular surgery may confer long-term benefits pro- 
vided bleeding is not a problem. 
D. E Mikhail idis and M. A. Barradas 
London, U.K. 
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